At the Heart Transplant Program at Boston Children’s Hospital, we evaluate infants, children and adolescents who are potential candidates for heart transplantations. We specialize in caring for children with end-stage heart disease. Since the program’s inception in 1986, we have performed more than 220 heart transplants.
Ranked No. 1 in the country by U.S.News & World Report
Close collaboration with the Interventional Catheterization Program
A leader in research and regulatory issues surrounding ventricular assist devices used in the United States
The Heart Transplant Program at Children’s Hospital Boston is one of the largest pediatric heart transplant centers in the country. Our multidisciplinary team is made up of:
- cardiac surgeons
- cardiac anesthesiologists
- advanced practice nurses
- physical therapists
- cardiac pathologists
- infectious disease specialists
- transplant pharmacists
- transplant coordinators
- social workers
- child life specialists
Together, we are dedicated to caring for some of the most acute cardiac patients in the country.
- More than 60 percent of heart transplant evaluations are for patients with complex congenital heart disease.
- The remainder of the patients evaluated for transplant have a diagnosis of cardiomyopathy that has failed maximal medical management.
Our program makes frequency use of Boston Children’s advanced cardiac catheterization lab. Here, we can visualize what’s happening in the heart in fine detail, and take measurements of blood pressure and flow. Our colleagues specializing in interventional cardiology can even make a number of repairs with catheterization, like expanding narrowed passages and closing holes.
Did you know?
Mechanical circulatory support
Boston Children’s physicians and nurses have played a leading role in the research and regulatory issues surrounding pediatric ventricular assist device (VAD) use in the United States. These devices give blood circulation a boost and can serve as a life-saving bridge to transplant. Boston Children’s cardiologist Christopher Almond, was integral in designing and conducting the multi-institutional study of the Berlin Heart®, which gained FDA approval for use in children in 2011. Boston Children’s continues to expand the field of VAD support in children by introducing new devices such as the HeartWare® HVAD allowing children to be discharged home and to resume activities of life. A Boston Children’s patient was the first child in North America to go back to school with a VAD as she waits for a heart transplant. Learn more.
Top ranking from U.S.News & World Report
In 2012, U.S.News & World Report ranked Boston Children’s programs in cardiology and cardiac surgery No. 1 in the nation among pediatric hospitals.
Danielle at 15, six years after heart transplant